Postischemic hypothermia provides long-lasting neuroprotection against global cerebral ischemia in adult rats and gerbils. Studies indicate that hypothermia must be prolonged (e.g., 24 h) to indefatigably salvage hippocampal CA1 neurons. Delayed hypothermia also reduces focal ischemic injury. However, no study has examined long-term outcome following postischemic hypothermia in adult animals. Furthermore, most studies examined only brief hypothermia (e.g., 3 h). Since previous studies may have overestimated long-term benefit and have likely used suboptimal durations of hypothermia, we examined whether prolonged cooling would attenuate infarction at a 2-month survival time following middle cerebral artery occlusion (MCAo) in rats. Adult male Wistar rats were implanted with telemetry brain temperature probes and later subjected to 30 min of normothermic MCAo (contralateral to side of probe placement) or sham operation. Ischemia was produced by the insertion of an intraluminal suture combined with systemic hypotension (60 mm Hg). Sham rats and one ischemic group controlled their own postischemic temperature while another ischemic group was cooled to 34°C for 48 h starting at 30 min following the onset of reperfusion. The infarct area was quantified after a 2-month survival time. Normothermic MCAo resulted in almost complete striatal destruction (91% loss ؎ 12 SD) with extensive cortical damage (36% ؎ 16 SD). Delayed hypothermia treatment significantly reduced cortical injury to 10% ؎ 10 SD (P < 0.001) while striatal injury was marginally reduced to 79% loss ؎ 17 SD (P < 0.05). Delayed hypothermia of only 34°C provided long-lasting cortical and striatal protection in adult rats subjected to a severe MCAo insult. These results strongly support the clinical assessment of hypothermia in acute stroke.
INTRODUCTION
Mild postischemic hypothermia conveys substantial and lasting protection of hippocampal CA1 neurons in gerbil (7, 8) and rat (12) models of global ischemia, provided that hypothermia is sufficiently long (e.g., 12-48 h). Indeed, 24 h of mild hypothermia induced 1 h after severe forebrain ischemia in the gerbil preserves Ϸ70% of CA1 neurons at 6-to 12-month survival times (8, 10) . Similarly, 2 days of mild hypothermia persistently (28 days) salvages most CA1 neurons in the rat four-vessel occlusion model even with a 6-h intervention delay (12) .
The efficacy of postischemic hypothermia after focal ischemia is not clear for two reasons. First, the maximal effectiveness and thereby the therapeutic window of delayed hypothermia has likely been underestimated in adult stroke models since optimal durations of hypothermia have not been assessed. Indeed, many studies (2, 25, 28, 43, 45, 46) have assessed only 1-3 h of postischemic hypothermia (30 -32°C) following middle cerebral artery occlusion (MCAo) in adult rats. Two of these studies indicate that somewhat longer durations (e.g., 3 h vs 1 h) are more effective in reducing infarction (25, 28) , while a third shows that 21 h of mild hypothermia is superior to a 1-h duration (44) . These data and the global ischemia studies (e.g., 7) strongly suggest that prolonged cooling (e.g., two days) might provide better protection for the treatment of focal cerebral ischemia than previously thought possible; although it is realized that at least some mechanisms, and thus the ideal therapy, may differ between global and focal ischemia.
A second limitation of previous work on hypothermia (25, 28, 44) is that they used early survival times (e.g., 48 h) and the full extent of ischemic injury may not have been evident. Neuronal injury, especially in pen-umbral regions, can mature over days or weeks after mild focal ischemia (17, 19, 20) . Also, hypothermia may just delay cell death after focal ischemia as has been found with brief duration hypothermia in global ischemia (14, 15) . This possibility is further suggested by pharmacological studies in global (11, 31) and focal ischemia (42) where drug treatments appeared effective at early (e.g., 4 -7 days) but not later (e.g., 30 days) time points. Therefore, infarction measurements based on short survival times (i.e., Ͻ1 week) could underestimate the complete extent of ischemic injury particularly after partially protective interventions.
The purpose of this study was to determine the efficacy of postischemic hypothermia in focal ischemia using a hypothermic duration similar to those that convey lasting protection in global ischemia models. More importantly, infarction was measured after a prolonged survival time of 60 days. This ensured that any observed protection was long-lasting and not merely a postponement of cell death. Demonstration of permanent protection is an important step prior to further experimentation and clinical investigation.
METHODS

Subjects
This experiment, which conformed to the guidelines of the Canadian Council on Animal Care and a local animal care committee, used male Wistar rats obtained from Charles River (St. Constant, Quebec, Canada). After an Ϸ1-week acclimation to the vivarium, rats (350 -450 g) were divided into three groups: SHAM (N ϭ 16), ISCH (N ϭ 17) and ISCH ϩ HYPO (N ϭ 12, 3 others died). Several other rats were excluded for technical reasons (e.g., could not insert the suture completely). Large rats were chosen to minimize the impact of impending weight loss (due to ischemia and hypothermia) on survival and brain injury.
Ischemia and Temperature Control
Rats were anesthetized with 65 mg/kg sodium pentobarbital and implanted at the dural surface with a 5.0-mm guide cannula 1 mm anterior and 1 mm to the left of bregma, as previously described (9) . Two days later 8.0-mm-long and 0.5-mm-wide telemetry brain temperature probes (Model XM-FH, Mini-Mitter Co., Sunriver, OR), chemically sterilized and rinsed in sterile saline, were inserted under brief halothane anesthesia. Cortical temperature (lower layers of anterior cingulate cortex) was sampled every 30 s while the rats were housed individually upon receivers (RLA-1020, DataSciences Int., St. Paul, MN) interfaced to a computer running DataQuest IV (DataSciences Int.).
Ischemia or sham occlusion surgery was done 4 days after cannula implantation. Rats were first anesthetized with 2.5% halothane in 60% N 2 O and 40% O 2 . Following intubation the animals were maintained on Ϸ1.0% halothane. Next the ventral tail artery was cannulated for measurement of blood pressure (BP) and for sampling of arterial blood gases. Adjustments were made to maintain normal blood gases (PaCO 2 35-42 mm Hg, PaO 2 90 -110 mm Hg, and pH 7.40). Following a ventral midline neck incision, the bifurcation of the right common carotid artery (CCA) was isolated. The external carotid artery (ECA) was severed and the distal portion was tied off while a 4-mm microvascular clip was placed on the ECA nearer to the bifurcation. Next ISCH and ISCH ϩ HYPO, but not SHAMs, had a 3-O nylon suture inserted into the ECA, the clamp removed, and the suture advanced up the internal carotid artery (ICA) until slight resistance was felt (i.e., Ϸ22 mm). A 6-O silk suture was then tightened on the ECA to prevent suture movement, and bleeding. Halothane was increased to 2.0 -2.5% to lower BP to 60 mm Hg. After 30 min of ischemia at a steady BP of 60 mm Hg, the suture was removed and BP was normalized to about 100 mm Hg. The ECA was tied off, wounds were closed, and the anesthetic and intubation were quickly discontinued.
A combined MCA occlusion with lowering of systemic pressure was chosen because a previous study had shown that combined occlusion with lowered BP resulted in consistent and predictable infarction and could produce an insult comparable to longer (e.g., 2 h) normotensive insults (48) . Our goal was to obtain a moderate-sized infarct without any significant sideeffects common with longer durations of ischemia (e.g., seizures, death). A 30-min occlusion was chosen because pilot data indicated that longer insult durations (e.g., 45 min) at a BP of 60 was associated with excessive morbidity. It is important to remember that temperature was strictly controlled in this study and, therefore, that the insult severity was probably increased relative to studies with less precise temperature control.
All rats had their rectal temperature maintained during surgery near 37.5°C while brain temperature (contralateral to ischemia) was regulated at 36.0 -36.5°C (normothermia) by a servo-controlled infrared lamp (9) . The SHAM and ISCH groups regulated their own temperature following ischemia, and this comparison allowed us to determine if, in this model, focal ischemia alters postischemic temperature since others have reported that hyperthermia follows this intraluminal suture model (29, 47) . The ISCH ϩ HYPO group was subjected to prolonged hypothermia starting 30 min after the end of ischemia (Fig. 1) . Hypothermia was slowly induced at a rate of 1.0°C/30 min until 34.0°C was reached. Rats were then kept near 34.0°C (with Ϸ 1 3°C range) for 48 h before rewarming to 35.0°C, after which temperature was held between 35.0 and 36.0°C for another 24 h prior to normothermia. Hypo-thermia was produced in the awake rat by a servocontrolled system that used fans and fine water spray to cool with infrared lamps to heat ( Fig. 1) (9) . After 96 h of data collection, rats were briefly anesthetized with halothane and their brain temperature probes were removed. All rats had continuous access to food (rat chow) and water throughout this procedure.
Histology
Sixty days following MCAo or sham operation the rats were humanely killed with an overdose of sodium pentobarbital (70 mg/kg, i.p.) and perfused with normal saline followed by 10% formalin. The brains remained in situ for at least 12 h prior to removal and later paraffin embedding. Brain sections were cut at 6 m and stained with hematoxylin and eosin. The extent of injury was quantified with an image analysis system (NIH Image software on a Macintosh computer) through standardized sections of the cortex (nine levels; see Fig. 2 ) and the caudate (four levels: 2.0, 0.5, Ϫ1.0, and Ϫ2.5 mm to bregma (33)) by a technician unaware of the treatment groups. The regions of infarction and dense gliosis were distinct from normal tissue due to the long survival time used (60 days). Accordingly, the area of normal cortical and caudate tissue remaining in the infarcted hemisphere was measured and expressed as a percentage of the noninfarcted hemisphere to control for differences in tissue processing and animal size.
RESULTS
Baseline brain temperature, which was collected the day prior to ischemia/sham operation, was similar among groups (24-h means: 36.8 -36.9°C with a mean of 36.5°C during the day and 37.3°C during the night). Physiological variables (e.g., brain temperature) were not significantly different between ischemic groups Note. There were no significant differences between ischemic groups.
FIG. 1.
Intra-and postischemic brain temperature (°C) in the SHAM, ISCH, and ISCH ϩ HYPO groups (top). Data were collected every 30 s, but are presented as 30-min averages. Awake rats were precisely cooled by intermittent water spray and frequent activation of a fan. Occasionally an infrared lamp was used to counteract excessive cooling (bottom). Notably, both SHAM and ISCH rats were normothermic following ischemia.
FIG. 2.
Cortical damage (2-month survival) expressed as a percentage (Ϯ SD) of the nonischemic hemisphere in SHAM, ISCH, and ISCH ϩ HYPO groups. Untreated ischemia resulted in severe cortical necrosis that was largely and significantly attenuated by delayed postischemic hypothermia (*P Ͻ 0.0055 (0.05/9), determined by simple effects from mixed ANOVA with ISCH and ISCH ϩ HYPO data included; the 0.05 ␣ level was corrected for nine comparisons Ϫ coronal levels).
during the occlusion ( Table 1) . The ISCH and SHAM animals had similar postischemic temperature profiles which were certainly within the normal range. Hypothermia was induced as desired in the ISCH ϩ HYPO group starting at 30 min following the end of ischemia (Fig. 1) .
All groups lost weight after ischemia. The SHAM group lost on average 25 g, while ISCH and ISCH ϩ HYPO groups lost Ϸ60 g by the fourth postischemic day. This weight loss had recovered in SHAMs by day 7, but was more persistently depressed in the ischemic groups. All groups weighted similarly by 30 days postischemia ( Table 2) .
None of the SHAM or ISCH rats died following successful ischemia. However, three ISCH ϩ HYPO rats died on days 2, 5, and 7 postischemia, but this mortality was not significantly different from the ISCH group (Fisher Exact test, P ϭ 0.092). The one death on the second postischemic day might have been due to hypoglycemia as a cardiac blood sample taken immediately following death showed a glucose level of 2.7 mmol/L. Immediate samples were not obtainable from the other two dead rats, but they did lose on average 91 g by the fourth postischemic day.
Quantification of the area of damage (Figs. 2 and 3 ) revealed that postischemic hypothermia significantly reduced cortical infarction (vs ISCH; main effect from ANOVA: F 1,27 ϭ 22.73, P Ͻ 0.001; interaction: F 8,216 ϭ 6.03, P Ͻ 0.001). Modest benefit was also seen in the striatum (F 1,27 ϭ 4.75, P Ͻ 0.04) where the mean area of striatal tissue was 9.2% of contralateral side Ϯ 11.9 SD in untreated ISCH group and 21.0% Ϯ 17.4 SD in the ISCH ϩ HYPO group (Fig. 4) .
DISCUSSION
Prolonged hypothermia (48 h at 34°C), initiated 30 min after the onset of reperfusion from MCAo in adult rats, significantly and persistently (60 days) reduced cortical and to a lesser extent striatal injury without significant mortality. This finding in the rat contrasts with early studies in cat and monkey MCAo models where 48 h of 29°C hypothermia was frequently lethal (30, 40) . While these strikingly different outcomes may represent a species effect, these early failures are more likely due to the greater prevalence of side-effects of moderate (i.e., Ͻ30°C) hypothermia (35) . The fact that humans can tolerate similarly long bouts of mild hypothermia (e.g., 32-34°C) (3, 4, 26, 27, 34, 37, 38) supports this contention.
The present finding of persistent neuroprotection is important since recent focal ischemia studies in adult animals that used brief (2, 25, 28, 43, 45, 46) or protracted (44) cooling relied upon 1-to 7-day survival times. Short survival times are problematic because Note. Data in parentheses represent the % loss or gain of weight from the day of ischemia.
FIG. 3.
Representative photomicrographs depicting the range of injury sustained in the ISCH (left) and ISCH ϩ HYPO rats (right). The cortical injury in the ISCH rats from the top was 25, 43 and 61%, respectively. The cortical injury in the ISCH ϩ HYPO rats was 4, 14, and 30% respectively. both global and focal ischemic insults may mature more slowly and initial neuroprotection is not necessarily permanent (e.g., MK-801 (42)). Thus, the present study is the first to show that postischemic hypothermia can persistently reduce injury in adult MCAo rats.
The reduction in cortical injury is impressive considering that the nontreated ISCH rats sustained 40 -60% loss across many cortical levels. Striatal protection, which is statistically significant, is less impressive. However, this is not surprising given that this model of focal ischemia produces a severe striatal insult (ischemia core) which develops into infarction within hours of the insult (18, 20, 32) . Furthermore, the present results are better than those reported by Karibe and colleagues (24) where a significant reduction in caudate infarction occurred only when hypothermia was applied prior to or within 10 min of ischemia. Cortical tissue, which is part of the penumbral zone, is presumably more amenable to therapy since cortical cell death matures more slowly than in the striatum (18, 20, 32) .
The duration and depth of hypothermia markedly affect neuroprotection in global ischemia (1, 10, 13) . Thus, studies of brief (e.g., 3 h) or mild hypothermia (e.g., Ͼ34°C) in focal ischemia may have markedly underestimated efficacy. Perhaps this is why we found protection with a 30 min postischemic delay while Yanamoto and colleagues (44) did not. One could argue that the difference in efficacy is due to the shorter duration of MCAo used in our study (30 min versus 3 h of MCAo). This is unlikely since the present combination of 30 min of ischemia with systemic hypotension resulted in massive brain injury. A more parsimonious explanation is that the very mild and variable drop in temperature (to Ն35°C for 18 of the 21 h) coupled with the shorter duration of hypothermia in their study (44) was less efficacious than our cooling protocol.
Studies in newborn and fetal models of hypoxiaischemia similarly suggest that delayed hypothermia reduces injury (21, 22, 39) . One study (39) in 21-day-old rats illustrates that 72 h of cooling is more efficacious than a 6-h duration and that persistent (3 weeks) cortical neuroprotection occurs with protracted hypothermia. As with the adult studies, the optimal pattern of hypothermia has yet to be defined.
The potential mechanisms underlying the protective actions of mild hypothermia were recently reviewed (1, 10) . These mechanisms include a reduction in metabolic rate, a more rapid normalization of pH and metabolism, an amelioration of postischemic hypoperfusion, reduced free radicals, reversal of second messenger alterations, and reduced glutamate release. This multitude of protective actions might explain why hypothermia is so effective compared to drug therapies (e.g., MK-801 (42)). Moreover, after ischemia, injurious cascades have different temporal profiles and thus prolonged hypothermia can potentially halt the evolution of these events. In contrast, neuroprotective drugs frequently have a short duration of action, which might be suboptimal. Unfortunately, many putative neuroprotectants have deleterious side-effects (e.g., hypotension, hallucinations, etc.) that preclude extended dosing regimens. Thus, hypothermia, while not free of complications (35) , may be preferable when efficacy and safety issues are considered. Notably prolonged mild hypothermia (Ն32°C) is safe in humans who have suffered a traumatic head insult (3, 4, 26, 27, 34, 37, 38) or stroke (36) .
One limitation of the present study and that of many earlier studies (e.g., 7, 8, 44) is that hypothermia was produced in the unanesthetized rodent. Shivering which, at least temporarily, accompanies hypothermia would elevate metabolism (16, 41) and potentially diminish neuroprotection since lowered metabolism is probably one of the mechanisms by which hypothermia protects (1, 10, 23) . Other neuroendocrine effects of unanesthetized hypothermia might also lessen protection. Given that these deleterious effects (e.g., shivering) would be prevented in humans (e.g., via anesthetic), it is likely that many animal studies of postischemic hypothermia have underestimated maximal efficacy. The hybrid (intraluminal suture ϩ hypotension) model of focal ischemia used in the present study produced severe injury (Fig. 3) . Thus, even more impressive results with hypothermia might occur in other focal ischemia models and such studies are in progress.
Another observation warrants discussion. Continual measurement of brain temperature showed that, under the present conditions, focal ischemia was not accompanied by postischemic hyperthermia as reported to occur in the suture model (29, 47) . Notably, spontaneous postischemic temperature alterations are common in rodents subjected to global ischemia with reports of both hypothermia (rat four-vessel occlusion ischemia (12) ) and hyperthermia (gerbil (7) and rat two-vessel occlusion plus hypotension (5, 6) ). While there are many possible reasons for such differences (e.g., the severity of ischemia (7)), it does underscore the need to always measure temperature. In conclusion, the present study shows that mild (2.5°C drop) postischemic hypothermia can provide long-term protection in focal ischemia, which previously had been demonstrated solely in global ischemia models (10, 12) . Future work should address additional concerns such as the optimal depth and duration of hypothermia and then determine the therapeutic window as we have done in global ischemia studies. More important, long-term benefit must be assessed. Such studies are in progress and will hopefully improve this therapy in time for upcoming clinical trials.
